Advertisement
Home »

Safety and Effectiveness of Cinnomer on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study.

Feb 05, 2024

ABOUT THE EXPERTS

  • Abdorreza Naser Moghadasi

    Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

    Fereshteh Ashtari

    Isfahan University of Medical sciences, Kashani Comprehensive MS Center, Isfahan, Iran.

    Seyed Mohammad Baghbanian

    Multiple Sclerosis Fellowship, Neurology Department, Boualicina Hospital, Mazandaran University of Medical Sciences, Sari, Iran.

    Vahid Shaygannejad

    Isfahan University of Medical sciences, Kashani Comprehensive MS Center, Isfahan, Iran.

    Nassim Anjidani

    Medical Department, Orchid Pharmed Company, Tehran, Iran.

    Fereshteh Ghadiri

    Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

    Behnaz Sedighi

    Neurology Research Center, Kerman University of Medical Science, Kerman, Iran.

    Morteza Saeidi

    Department of Neurology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

    Hamed Amirifard

    Department of Neurology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

    Hormoz Ayromlou

    Neurology Department, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran.

    Nahid Beladi Moghadam

    Department of Neurology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

    Mohammad Bagher Ranjbar

    Pastour Building, Shiraz, Iran.

    Masoume Nazeri

    Clinical Neurology Research Center, Department of Neurology, Shiraz University of Medical Sciences, Shiraz, Iran.

    Zahra Niknam

    Kosar Hospital, Shiraz, Iran.

    Fardin Faraji

    Department of Neurology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.

    Afsaneh Afsorde

    Sina Building, Shiraz, Iran.

    Mohammad Ali Sahraian

    Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement